Glucose oxidase and metal catalysts combined tumor synergistic therapy: mechanism, advance and nanodelivery system

Table 1 Differences between the various synergistic therapies

Therapy model	Initiator	Restricted condition in therapy	Tumor-killing pathways	Representative Refs.
ST	GOx	Glucose and O₂	Consumption of glucose	[59]
CDT	Fenton agent	H₂O₂	ROS	[46]
PDT	Light/PSs	O₂	ROS	[33]
SDT	US/SSs	O₂	ROS	[37]
EDT	Electricity/electrocatalyst	H₂O	ROS	[56]
PTT	Light/PTAs	/	Heat	[58, 60]
CT	Chemotherapy drug	/	Direct or simplified inhibition or killing	[57, 61]
IMT	ICD inducers or others	/	Antitumor immunity	[48]

ISSN: 1477-3155